| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $906,794 ) |
| | 2025 | 2025 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY032994 | In vivo Imaging of the Human Retina at the Molecular Level | 000 | 2 | NIH | 2/20/2025 | $514,294 |
| | 2025 | 2025 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY033905 | Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species | 000 | 3 | NIH | 3/26/2025 | $392,500 |
| | 2025 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 000 | 11 | NIH | 5/14/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $2,886,587 ) |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY028554 | Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | 003 | 7 | NIH | 7/1/2024 | $619,785 |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY033905 | Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species | 000 | 2 | NIH | 4/15/2024 | $392,500 |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | U01EY034669 | Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | 000 | 3 | NIH | 8/23/2024 | $373,670 |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY032994 | In vivo Imaging of the Human Retina at the Molecular Level | 000 | 1 | NIH | 2/21/2024 | $532,924 |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030614 | Epidemiology of Biomarkers of AMD Progression | 000 | 3 | NIH | 8/15/2024 | $585,469 |
| | 2024 | 2024 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY034218 | In Vivo Characterizations of Retinal Hemodynamics | 000 | 3 | NIH | 7/29/2024 | $381,585 |
| | 2024 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY028554 | Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | 002 | 5 | NIH | 1/3/2024 | $654 |
| | 2024 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R21EY029839 | Artificial Intelligence for Assessment of Stargardt Macular Atrophy | 000 | 2 | NIH | 8/5/2024 | $0 |
| | 2024 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY028242 | Role of Retinal Capillary Stiffness in Diabetic Retinopathy | 000 | 6 | NIH | 4/10/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,553,508 ) |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | U01EY034669 | Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | 001 | 2 | NIH | 9/8/2023 | $382,058 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY033905 | Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species | 000 | 1 | NIH | 7/21/2023 | $392,500 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY028554 | Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | 000 | 6 | NIH | 6/23/2023 | $621,768 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY024378 | In vivo Ultrastructure of Chorioretinal Disease | 000 | 9 | NIH | 8/18/2023 | $351,475 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030141 | Novel Mechanisms of Subretinal Fibrosis in Age-related Macular Degeneration | 000 | 4 | NIH | 4/19/2023 | $363,593 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030614 | Epidemiology of Biomarkers of AMD Progression | 000 | 2 | NIH | 8/28/2023 | $582,584 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY034218 | In Vivo Characterizations of Retinal Hemodynamics | 000 | 2 | NIH | 8/3/2023 | $387,575 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 000 | 11 | NIH | 1/5/2023 | $424,759 |
| | 2023 | 2023 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 001 | 11 | NIH | 2/22/2023 | $47,196 |
| | 2023 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | U01EY034669 | Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | 000 | 1 | NIH | 3/27/2023 | $0 |
| | 2023 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY034218 | In Vivo Characterizations of Retinal Hemodynamics | 001 | 1 | NIH | 8/4/2023 | $0 |
| | 2023 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R21EY029839 | Artificial Intelligence for Assessment of Stargardt Macular Atrophy | 000 | 2 | NIH | 1/6/2023 | $0 |
| | 2023 | 2020 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R21EY030619 | Discovery and Validation of AMD Biomarkers for Progression Using Deep Learning | 000 | 2 | NIH | 4/4/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,155,828 ) |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY028554 | Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration | 001 | 5 | NIH | 9/20/2022 | $666,841 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY024378 | In vivo Ultrastructure of Chorioretinal Disease | 002 | 8 | NIH | 8/15/2022 | $342,101 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 000 | 10 | NIH | 12/17/2021 | $424,758 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030141 | Novel Mechanisms of Subretinal Fibrosis in Age-related Macular Degeneration | 000 | 3 | NIH | 4/25/2022 | $352,508 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | U01EY034669 | Deciphering the mechanisms associated with high-risk AMD genotypes for ARMS2/HTRA1 andComplement Factor H | 000 | 1 | NIH | 9/20/2022 | $418,893 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 001 | 10 | NIH | 6/29/2022 | $33,038 |
| | 2022 | 2022 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY034218 | In Vivo Characterizations of Retinal Hemodynamics | 000 | 1 | NIH | 9/20/2022 | $393,588 |
| | 2022 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030614 | Epidemiology of Biomarkers of AMD Progression | 000 | 1 | NIH | 8/11/2022 | $0 |
| | 2022 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030614 | Epidemiology of Biomarkers of AMD Progression | 001 | 1 | NIH | 9/16/2022 | $0 |
| | 2022 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY024378 | In vivo Ultrastructure of Chorioretinal Disease | 001 | 7 | NIH | 3/29/2022 | $211 |
| | 2022 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030501 | Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | 004 | 2 | NIH | 8/18/2022 | -$148,054 |
| | 2022 | 2021 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030501 | Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | 000 | 2 | NIH | 3/21/2022 | -$269,074 |
| | 2022 | 2020 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY030501 | Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye | 003 | 1 | NIH | 8/18/2022 | -$58,771 |
| | 2022 | 2019 | DOHENY EYE INSTITUTE | 150 N ORANGE GROVE BLVD | PASADENA | CA | 91103-3534 | LOS ANGELES | USA | R01EY024378 | In vivo Ultrastructure of Chorioretinal Disease | 000 | 6 | NIH | 3/29/2022 | -$211 |
|
| Issue Date FY: 2021 ( Subtotal = $3,026,989 ) (Continued on the next page) |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY030614 | Epidemiology of Biomarkers of AMD Progression | 000 | 1 | NIH | 9/15/2021 | $640,560 |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY030141 | Novel Mechanisms of Subretinal Fibrosis in Age-related Macular Degeneration | 000 | 2 | NIH | 4/23/2021 | $352,335 |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R21EY029839 | Artificial Intelligence for Assessment of Stargardt Macular Atrophy | 000 | 2 | NIH | 12/14/2020 | $176,625 |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 000 | 9 | NIH | 12/17/2020 | $424,758 |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY018827 | Role of IL-17+ Autoreactive T Cells in Experimental Autoimmune Uveitis (EAU) | 001 | 9 | NIH | 2/22/2021 | $33,038 |
| | 2021 | 2021 | DOHENY EYE INSTITUTE | 1355 SAN PABLO ST | LOS ANGELES | CA | 90033-1035 | LOS ANGELES | USA | R01EY024378 | In vivo Ultrastructure of Chorioretinal Disease | 002 | 7 | NIH | 9/21/2021 | $339,483 |
|
